|
1
|
Wynder EL and Graham EA: Landmark article
May 27, 1950: Tobacco Smoking as a possible etiologic factor in
bronchiogenic carcinoma. A study of six hundred and eighty-four
proved cases. By Ernest L. Wynder and Evarts A. Graham. JAMA.
253:2986–2994. 1985. View Article : Google Scholar
|
|
2
|
Schiller JH, Harrington D, Belani CP, et
al: Comparison of four chemotherapy regimens for advanced
non-small-cell lung cancer. N Engl J Med. 346:92–98. 2002.
View Article : Google Scholar
|
|
3
|
Ohe Y, Ohashi Y, Kubota K, et al:
Randomized phase III study of cisplatin plus irinotecan versus
carboplatin plus paclitaxel, cisplatin plus gemcitabine, and
cisplatin plus vinorelbine for advanced non-small-cell lung cancer:
Four-Arm Cooperative Study in Japan. Ann Oncol. 18:317–323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Paez JG, Janne PA, Lee JC, et al: EGFR
mutations in lung cancer: correlation with clinical response to
gefitinib therapy. Science. 304:1497–1500. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lynch TJ, Bell DW, Sordella R, et al:
Activating mutations in the epidermal growth factor receptor
underlying responsiveness of non-small-cell lung cancer to
gefitinib. N Engl J Med. 350:2129–2139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kosaka T, Yatabe Y, Endoh H, Kuwano H,
Takahashi T and Mitsudomi T: Mutations of the epidermal growth
factor receptor gene in lung cancer: biological and clinical
implications. Cancer Res. 64:8919–8923. 2004. View Article : Google Scholar
|
|
7
|
Lee YJ, Shim HS, Kang YA, et al: Dose
effect of cigarette smoking on frequency and spectrum of epidermal
growth factor receptor gene mutations in Korean patients with
non-small cell lung cancer. J Cancer Res Clin Oncol. 136:1937–1944.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pham D, Kris MG, Riely GJ, et al: Use of
cigarette-smoking history to estimate the likelihood of mutations
in epidermal growth factor receptor gene exons 19 and 21 in lung
adenocarcinomas. J Clin Oncol. 24:1700–1704. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jida M, Toyooka S, Mitsudomi T, et al:
Usefulness of cumulative smoking dose for identifying the EGFR
mutation and patients with non-small-cell lung cancer for gefitinib
treatment. Cancer Sci. 100:1931–1934. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wilson DO, Weissfeld JL, Balkan A, et al:
Association of radiographic emphysema and airflow obstruction with
lung cancer. Am J Respir Crit Care Med. 178:738–744. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maldonado F, Bartholmai BJ, Swensen SJ,
Midthun DE, Decker PA and Jett JR: Are airflow obstruction and
radiographic evidence of emphysema risk factors for lung cancer? A
nested case-control study using quantitative emphysema analysis.
Chest. 138:1295–1302. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cottin V, Nunes H, Brillet PY, et al:
Combined pulmonary fibrosis and emphysema: a distinct
underrecognised entity. Eur Respir J. 26:586–593. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Usui K, Tanai C, Tanaka Y, Noda H and
Ishihara T: The prevalence of pulmonary fibrosis combined with
emphysema in patients with lung cancer. Respirology. 16:326–331.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kitaguchi Y, Fujimoto K, Hanaoka M,
Kawakami S, Honda T and Kubo K: Clinical characteristics of
combined pulmonary fibrosis and emphysema. Respirology. 15:265–271.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kenmotsu H, Naito T, Kimura M, et al: The
risk of cytotoxic chemotherapy-related exacerbation of interstitial
lung disease with lung cancer. J Thorac Oncol. 6:1242–1246. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goddard PR, Nicholson EM, Laszlo G and
Watt I: Computed tomography in pulmonary emphysema. Clin Radiol.
33:379–387. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bergin C, Muller N, Nichols DM, et al: The
diagnosis of emphysema. A computed tomographic-pathologic
correlation. Am Rev Respir Dis. 133:541–546. 1986.PubMed/NCBI
|
|
18
|
Ferguson GT, Enright PL, Buist AS and
Higgins MW: Office spirometry for lung health assessment in adults:
A consensus statement from the National Lung Health Education
Program. Chest. 117:1146–1161. 2000. View Article : Google Scholar
|
|
19
|
Nagai Y, Miyazawa H, Huqun, et al: Genetic
heterogeneity of the epidermal growth factor receptor in non-small
cell lung cancer cell lines revealed by a rapid and sensitive
detection system, the peptide nucleic acid-locked nucleic acid PCR
clamp. Cancer Res. 65:7276–7282. 2005. View Article : Google Scholar
|
|
20
|
Takano T, Ohe Y, Sakamoto H, et al:
Epidermal growth factor receptor gene mutations and increased copy
numbers predict gefitinib sensitivity in patients with recurrent
non-small-cell lung cancer. J Clin Oncol. 23:6829–6837. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee YJ, Cho BC, Jee SH, et al: Impact of
environmental tobacco smoke on the incidence of mutations in
epidermal growth factor receptor gene in never-smoker patients with
non-small-cell lung cancer. J Clin Oncol. 28:487–492. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Usui K, Ushijima T, Tanaka Y, et al: The
frequency of epidermal growth factor receptor mutation of nonsmall
cell lung cancer according to the underlying pulmonary diseases.
Pulm Med. 2011:2901322011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gullon JA, Suarez I, Medina A, Rubinos G,
Fernandez R and Gonzalez I: Role of emphysema and airway
obstruction in prognosis of lung cancer. Lung Cancer. 71:182–185.
2011. View Article : Google Scholar
|
|
24
|
de Torres JP, Bastarrika G, Wisnivesky JP,
et al: Assessing the relationship between lung cancer risk and
emphysema detected on low-dose CT of the chest. Chest.
132:1932–1938. 2007.PubMed/NCBI
|
|
25
|
Smith BM, Pinto L, Ezer N, Sverzellati N,
Muro S and Schwartzman K: Emphysema detected on computed tomography
and risk of lung cancer: a systematic review and meta-analysis.
Lung Cancer. 77:58–63. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamada N, Yamaya M, Okinaga S, et al:
Microsatellite polymorphism in the heme oxygenase-1 gene promoter
is associated with susceptibility to emphysema. Am J Hum Genet.
66:187–195. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kikuchi A, Yamaya M, Suzuki S, et al:
Association of susceptibility to the development of lung
adenocarcinoma with the heme oxygenase-1 gene promoter
polymorphism. Hum Genet. 116:354–360. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
D'Angelo SP, Pietanza MC, Johnson ML, et
al: Incidence of EGFR exon 19 deletions and L858R in tumor
specimens from men and cigarette smokers with lung adenocarcinomas.
J Clin Oncol. 29:2066–2070. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morita S, Okamoto I, Kobayashi K, et al:
Combined survival analysis of prospective clinical trials of
gefitinib for non-small cell lung cancer with EGFR mutations. Clin
Cancer Res. 15:4493–4498. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rosell R, Moran T, Queralt C, et al:
Screening for epidermal growth factor receptor mutations in lung
cancer. N Engl J Med. 361:958–967. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sanchez-Cespedes M, Ahrendt SA, Piantadosi
S, et al: Chromosomal alterations in lung adenocarcinoma from
smokers and nonsmokers. Cancer Res. 61:1309–1313. 2001.PubMed/NCBI
|
|
32
|
Shukuya T, Takahashi T, Kaira R, et al:
Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung
cancer patients harboring epidermal growth factor receptor
mutations: a pooled analysis of published reports. Cancer Sci.
102:1032–1037. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Castillo L, Etienne-Grimaldi MC, Fischel
JL, Formento P, Magne N and Milano G: Pharmacological background of
EGFR targeting. Ann Oncol. 15:1007–1012. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kudoh S, Kato H, Nishiwaki Y, et al:
Interstitial lung disease in Japanese patients with lung cancer: a
cohort and nested case-control study. Am J Respir Crit Care Med.
177:1348–1357. 2008. View Article : Google Scholar : PubMed/NCBI
|
